Eloxx Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Eloxx Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2023.
Eloxx Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -1.31 USD/shares, a 62.2% increase year-over-year.
Eloxx Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -9.07 USD/shares.
Eloxx Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -16.7 USD/shares, a 56.4% increase from 2021.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	-$9	-$1	+$2.16	+62.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	-$11	-$2	+$2.94	+60%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	-$14	-$3	+$2.48	+46.3%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	-$17	-$3			Oct 1, 2022	Dec 31, 2022	10-K	2023-03-31
Q3 2022		-$3	-$3	-3055%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022		-$5	-$4	-807%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022		-$5			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q3 2021		$0			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10
Q2 2021		-$1			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.